|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Sami MalekPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: Softcover reprint of the original 1st ed. 2013 Volume: 792 Dimensions: Width: 15.50cm , Height: 1.80cm , Length: 23.50cm Weight: 0.718kg ISBN: 9781493953899ISBN 10: 1493953893 Pages: 334 Publication Date: 23 August 2016 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPreface.- B-cell receptor and antigens in CLL.- The CLL cell microenvironment.- Acquired genomic copy number aberrations in CLL.- Recurrent gene mutations in CLL.- TP53 aberrations in CLL.- Gene expression and epigenetic deregulation.- Apoptosis deregulation in CLL.- Richter’s Syndrome.- Molecular biomarkers in chronic lymphocytic leukemia.- Critical Signal Transduction Pathways in CLL.- Immunotherapies in CLL.- Novel therapeutic agents in CLL.- Inherited susceptibility to CLL.- miR deregulations in CLL.- Index.ReviewsAuthor InformationSami N. Malek is an Associate Professor at the Department of Internal Medicine at the University of Michigan Health System. Dr. Malek's research interests include basic and translational questions in Leukemia and Lymphoma. Well known in the field of CLL, Dr. Malek is well-published in the area and is invited to international conferences and seminars to give talks on the topic. Tab Content 6Author Website:Countries AvailableAll regions |